ArticleEndocrine-related cancer2012

mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer.

Matthew J Schiewer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.